326030 - SK biopharmaceuticals Co., Ltd.

326030 Summary
Biopharma
Stock Price & Overview
₩86,600 +200 (+0.23%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩86,600  ≈ US$62  ·  Market cap ₩6.8tn (≈ $4.8bn)

Material matter: joint research and development partnership signed with Insilico Medicine

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항 (Insilico Medicine과의 공동연구개발 파트너십 계약 체결)